Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01704833 · ClinicalTrials.gov registry record · NA
Cognitive Behavioral Therapy for Paranoia in Schizophrenia
A NA study of Paranoid Delusions, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT01704833: Completed NA study of Paranoid Delusions, sponsored by Weill Medical College of Cornell University.
NCT01704833 is a NA study of Paranoid Delusions that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01704833, a NA study of Paranoid Delusions, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The main objective of this study is to determine the preliminary efficacy of Paranoia-Focused Cognitive Behavioral Therapy (PFCBT) relative to standard care in the treatment of persecutory delusions in patients diagnosed with schizophrenia or schizoaffective Disorder.
Primary Outcome
Measured by the Persecution sub-scale on Positive and Negative Syndrome Scale (PANSS).
Conditions Studied
Interventions
- BEHAVIORAL Paranoia-Focused Cognitive Behavioral Therapy (PFCBT)
Study Locations (1)
New York
- Weill Cornell Medical College - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2006-09 |
| Est. Completion | 2017-06 |
| Phase | NA |
What the finished NCT01704833 record still lists
NCT01704833 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Paranoid Delusions appearing as the primary indexed condition, and to 1 intervention - of which Paranoia-Focused Cognitive Behavioral Therapy (PFCBT) is the first listed.
NCT01704833 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01704833 about?
NCT01704833 is a clinical study titled "Cognitive Behavioral Therapy for Paranoia in Schizophrenia". The main objective of this study is to determine the preliminary efficacy of Paranoia-Focused Cognitive Behavioral Therapy (PFCBT) relative to standard care in the treatment of persecutory delusions in patients diagnosed with schizophrenia or schizoaffective Disorder.
What is the current status of trial NCT01704833?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2006-09. Estimated completion is 2017-06.
What conditions does trial NCT01704833 study?
This clinical trial studies the following conditions: Paranoid Delusions.
What interventions are being tested in trial NCT01704833?
The interventions under investigation include: Paranoia-Focused Cognitive Behavioral Therapy (PFCBT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01704833?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01704833 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01704833's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia